Preclinical evidence demonstrated that ketogenic diet was able to reduce spikes in serum insulin and glucose and suppress downstream PI3K/mTOR signaling in PI3Ki-treated mice better than metformin, and also improve response to PI3Ki in multiple tumor types including breast cancer [4,45,46]. The gene discussed is MTOR; the disease is neoplasm.